🇺🇸 FDA
Patent

US 9463233

Avirulent, immunogenic flavivirus chimeras

granted A61KA61K2039/5254A61K2039/5256

Quick answer

US patent 9463233 (Avirulent, immunogenic flavivirus chimeras) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Oct 06 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Oct 11 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 06 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K2039/5254, A61K2039/5256, A61K2039/53, A61K2039/70